Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis

Optimized variants of anti-VEGF antibodies and methods of treatment thereof by reducing or inhibiting angiogenesis

US Patent 10072075 · Granted Sep 11, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD96 antibodies and methods of use thereof2025
Optimized variants of anti-VEGF antibodies2024
Optimized variants of anti-VEGF antibodies2024
Optimized variants of anti-VEGF antibodies2024
Optimized variants of anti-VEGF antibodies2024
Optimized variants of anti-VEGF antibodies2024
Anti-ULBP6 antibodies2024
Anti-ULBP6 antibodies2024
Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)2024
Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)2024
Dual specific antibodies for binding interleukin 4 (IL4) and interleukin 5 (IL5)2024
Methods of treating ocular disorders by administering a VEGF-binding antibody co2024